Recursive’s $400 million outlay represents the bulk of the company’s fundraising to date.
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
1. Selected dates can't be greater than July 2026. 2. From date can't be greater than To date. 1. Selected dates can't be greater than July 2026. 2. From date can't be greater than To date. 1. From & ...
Oracle and AWS expand long-term strategic collaboration agreement to accelerate customer migration, with Oracle AI Database@AWS now available in 22 AWS Regions and offering new expanded ...
See Statistics Help for definitions of terms used.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results